WO1994022522A1 - Medical devices having antimicrobial properties and methods of making and using - Google Patents
Medical devices having antimicrobial properties and methods of making and using Download PDFInfo
- Publication number
- WO1994022522A1 WO1994022522A1 PCT/US1994/002327 US9402327W WO9422522A1 WO 1994022522 A1 WO1994022522 A1 WO 1994022522A1 US 9402327 W US9402327 W US 9402327W WO 9422522 A1 WO9422522 A1 WO 9422522A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antimicrobial agent
- access control
- control member
- fluid path
- synthetic resin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/88—Draining devices having means for processing the drained fluid, e.g. an absorber
- A61M1/882—Draining devices provided with means for releasing antimicrobial or gelation agents in the drained fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/10—Tube connectors; Tube couplings
- A61M39/16—Tube connectors; Tube couplings having provision for disinfection or sterilisation
- A61M39/162—Tube connectors; Tube couplings having provision for disinfection or sterilisation with antiseptic agent incorporated within the connector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/10—Tube connectors; Tube couplings
- A61M2039/1072—Tube connectors; Tube couplings with a septum present in the connector
Definitions
- This invention relates to disposable medical devices, and more particularly to medical devices having antimicrobial properties and methods of making and using such devices.
- nosocomial infections stems from the use of medical devices and systems incorporating medical devices, such as fluid administration sets and blood pressure monitoring sets, for example, in which fluids received by a patient (i.e., blood, plasma, saline, etc.) contact the devices and pick up infection-causing bacteria.
- a patient i.e., blood, plasma, saline, etc.
- the present invention encompasses medical devices having antimicrobial properties, systems incorporating such devices, and methods of making and using such devices.
- the invention has particular applicability to fluid administration sets and pressure monitoring sets, and the medical device components thereof which contact fluids that in turn contact patients.
- the present invention contemplates a wide variety of medical devices, including valves, injection sites, stopcocks, manifolds, dead-enders, and both movable and resilient plug bodies, such as the septums in sample site devices.
- one embodiment of the invention is directed to medical devices which include a housing having a fluid path therein and at least one port for coupling to a source of fluid.
- the device further includes a member associated with the housing which is in communication with the fluid path to selectively control access to the fluid path.
- This member referred to herein as an "access control member,” has a composition comprising a synthetic resin material and an antimicrobial agent.
- Suitable synthetic resin materials include high density polyethylene (HDPE) , polyurethane, polycarbonate, etc.
- antimicrobial agent it is known that certain metal ions such as silver, copper, zinc, and derivatives thereof, are "oligodynamic"; in other words, they exhibit antimicrobial activity, and thus can be utilized as the active component in the antimicrobial agent in devices of the present invention.
- the housings of medical devices according to the present invention have substantially no antimicrobial agent molded therein.
- the access control member associated with the housing and which communicates with the fluid path does include an antimicrobial agent exposed on at least one surface which communicates with the fluid path in the housing.
- suitable antimicrobial materials are glass microspheres, platelets or fibers coated with elemental silver. It will be appreciated by persons skilled in the art, however, that various other known antimicrobial materials can be utilized in the devices of the present invention.
- the access control member is comprised of synthetic resin in the range of about 75% to 99% by weight, and antimicrobial agent in the range of about 1% to 25% by weight.
- the access control member of the device has an antimicrobial agent surface layer adhesively secured to a surface thereof which is in communication with the fluid path in the housing.
- the access control member of the medical device has an antimicrobial agent at least partially exposed on at least one surface thereof and which is applied thereto by ion beam implantation.
- Another aspect of the present invention relates to methods of making medical device components which include a synthetic resin material and an antimicrobial agent. Methods according to this aspect of the invention preferably include the steps of (1) compounding a synthetic resin material and an antimicrobial agent to form a mixture; (2) molding the mixture to produce a medical device component (access control member) ; and (3) ablating at least one surface of the component to at least partially expose the antimicrobial agent.
- the ablating step may comprise exposing the component or a specific desired surface thereof to an oxygen- containing plasma. This step is believed to remove small amounts of the resin material at the surface layer to expose the antimicrobial agent to a greater extent than may otherwise occur during the molding step.
- Yet another aspect of the present invention is directed to methods of reducing the incidence of nosocomial infections in patients who are exposed to fluids susceptible of containing infection-causing bacteria. Methods according to this aspect of the invention comprise coupling the fluid into a housing having a fluid path therein and at least one port for coupling to a source of the fluid.
- an access control member is of the type described hereinabove and has a composition which includes a synthetic resin material and an effective amount of an antimicrobial agent to kill infection-causing bacteria in the fluid.
- systems for adminstering fluid to patients include a fluid source; a fluid conduit connected to the fluid source and adapted to be placed in fluidic communication with a patient; a housing having a fluid path and at least two ports for coupling the fluid path in series with the fluid conduit; and an access control member associated with the housing and in communication with the fluid path for selectively controlling access to the fluid path.
- the access control member has a composition comprising a synthetic resin material and an antimicrobial agent.
- the antimicrobial agent may be of any suitable type, particularly any of those described herein, and the access control member may be a valve, a dead end plug, a movable plug body, a resilient plug body, a syringe plunger, etc.
- Fig. 1 is a perspective view, partially broken away, of a medical device (stopcock) according to one embodiment of the present invention
- Fig. 2A is a perspective view of two medical devices (stopcock and dead-ender) of the present invention coupled together;
- Fig. 2B is a cross-sectional view of the dead-ender shown in Fig. 2A with a portion of the stopcock shown in phantom;
- Fig. 3 is a cross-sectional view, partially broken away, of an alternative embodiment of a medical device (sample site) of the present invention
- Fig. 4 is a plan view, partially broken away and in partial cross-section, of another alternative embodiment (syringe with plunger) of the present invention.
- Fig. 5 is a schematic representation of a fluid administration system according to the present invention
- Fig. 6A is a schematic representation, in cross-section, of an access control member of the present invention
- Fig. 6B shows the access control member of Fig. 6A subsequent to a surface treatment in accordance with the principles of the present invention
- Fig. 7 is a schematic representation, in cross-section, of an alternative embodiment of an access control member of the present invention
- Fig. 8 is a schematic representation, in cross-section, of another alternative embodiment of an access control member of the present invention.
- medical devices which include a housing having a fluid path therein, at least one port for coupling to a source of fluid, and an access control member associated with the housing which is in communication with the fluid path for selectively controlling access to the fluid path.
- Figs. 1-4 show specific examples of medical device embodiments of the present invention.
- Fig. 5 is a schematic representation of a fluid administration system in accordance with the present invention and which incorporates medical devices of the present invention.
- Figs. 6A-8 are schematic representations of alternative embodiments of access control members.
- a stopcock 10 which includes a housing 12 having a fluid path 14 therein and a plurality of ports 15 adapted to be coupled to a fluid source. Fluids which may contain infection-causing bacteria and which contact a patient will flow through fluid path 14 during use of device 10. Stopcock 10 further includes an access control member such as valve 16 which is in communication with fluid path 14 and selectively controls access to the fluid path. Valve 16 is comprised of a synthetic resin material and an antimicrobial agent. With reference to Figs. 6A and B, there is shown alternative embodiments, in schematic form and in cross-section, of a portion designated generally as 20, of an access control member, which comprises a synthetic resin material designated generally as 22 and an antimicrobial agent molded therein designated generally as 24.
- a suitable antimicrobial agent which will be described hereinbelow, is compounded with a synthetic resin material and molded to form the medical device component, such as the access control member (valve) 16 of Fig. 1.
- portion 20 has the antimicrobial agent 24 at least partially exposed at a surface 26 thereof.
- surface 26 may be subjected to a treatment, such as plasma etching, to remove resin 22 from the surface layer to thereby expose additional antimicrobial, as represented in schematic form in Fig. 6B.
- the new surface is designated 26'. Suitable surface treatments for exposing additional antimicrobial agent will be described hereinafter.
- Fig. 2A shows an alternative embodiment of a medical device of the present invention. More particularly, the device shown is a dead-ender 28 received in a port 30 of a stopcock 10.
- Fig. 2B shows dead-ender 28 in cross-section, with port 30 of stopcock 10 shown in phantom.
- Dead-ender 28 comprises a synthetic resin material 22 having an antimicrobial agent 24 dispersed therein.
- stem portion 32 engages port 30 in a friction fit and thus communicates with fluid path 14 to selectively control access to that fluid path.
- Fig. 3 shows another alternative medical device in accordance with the principles of the present invention. Shown is a sample site or injection site device 34 which comprises a housing 36 having a fluid path 38 therein, and an access control member 40 which communicates with fluid path 38 to selectively control access to the fluid path.
- access control member 40 may take the form of a resilient plug such as a rubber septum 42 having an antimicrobial agent 44 molded therein.
- access control member 40 could be a valve such as seal member 38 shown and described in U.S. patent application Serial No. 07/855,147, filed March 20, 1992, the disclosure of which is fully incorporated herein by reference.
- Syringe 46 has a housing 48 with a fluid path 50 therein. Syringe 46 further includes a plunger 52 which is in communication with and selectively controls access to fluid path 50. Plunger 52 is preferably comprised of a synthetic resin material, such as rubber, having an antimicrobial agent molded therein, as shown.
- Fig. 7 shows, in sc ⁇ matic form, an alternative embodiment of a portion of an access control member for use in medical devices of the present invention.
- access control member portion 60 has a layer 62 containing an antimicrobial agent 63 adhesively secured thereto along a surface 64. Antimicrobial-containing layer 62 is preferably secured to a surface 64 which is in communication with a fluid path in the medical device.
- Fig. 8 is a schematic representation of an alternative access control member portion 66 in which a surface 68 thereof, which is to be in communication with a fluid path in a medical device, has an antimicrobial agent 70 implanted therein by ion beam implantation, as described in greater detail below.
- Fig. 5 is a schematic representation of a blood pressure monitoring/blood sampling system 100. The present invention is also intended to encompass although not specifically shown, systems such as fluid administration sets.
- System 100 shows a catheter 102 inserted into a patient 103 and connected by tubing 104 to a sample site device 34, which may be of the type shown in Fig. 3.
- Tubing 104 also connects sample site 34 to stopcock 10, which may be of the type shown herein in Fig.
- Tubing 104 is further connected to a source of saline 110.
- saline source 110 may be pressurized by pressure infuser 112 and its associated squeeze bulb 114.
- Another stopcock 10 is included in the tubing line between squeeze bulb 114 and pressure infuser 112.
- fluid samples may be withdrawn from system 100 via sample site 34 by means of a syringe 46, which may be of the type shown in Fig. 4.
- a syringe 46 which may be of the type shown in Fig. 4.
- the housing portion is typically molded polycarbonate, which possesses desirable strength qualities while being transparent.
- Access control members utilized in stopcocks and dead- enders, as described herein, are preferably molded of high density polyethylene (HDPE) .
- Other access control members, such as the resilient plugs in injection and sample site devices are typically molded of elastomeric materials, such as latex. It will be appreciated by persons skilled in the art, however, that various other synthetic resin materials, or natural materials may be utilized in the practice of the present invention without departing from the scope thereof.
- Various antimicrobial agents have been identified which may be used in the devices of the present invention.
- HAP synthetic hydroxyapatite
- SGA Sangi Group America
- CA Los Angeles
- APACIDER-AW APACIDER-AW
- silver- coated solid glass spheres may also be utilized as the antimicrobial agent.
- CONDUCT-O-FIL silver-coated glass microspheres which have been found to be particularly useful in the practice of the present invention, are available from Potters Industries, Inc. of Parsippany, NJ, under the trade designations S-2429-S and S-5000-S2.
- silver- coated glass platelets and fibers may also be successfully utilized; such materials are available from the PQ Corporation of Chattanooga, TN, under the trade names "AgClad Platelets” and "AgClad Filaments.” While the specific materials identified above incorporate silver as the metal ion having antimicrobial properties, it will be appreciated that other metal ions such as copper and zinc, and derivatives thereof, may also possess suitable antimicrobial properties for use in medical devices according to the present invention.
- the present invention further encompasses methods of making medical devices, and particularly the component parts thereof containing the antimicrobial material.
- a synthetic resin such as high density polyethylene, in the range of about 75% to 99% by weight, is compounded with an antimicrobial agent in the range of about 1% to 25% by weight, and which may be any one of the above described materials, or any other suitable antimicrobial material, to form a mixture thereof.
- This mixture is subsequently molded, e.g., by injection molding, to form the desired medical device component.
- the components molded in this manner are typically the access control members used in the medical devices as described herein, since those members will contact the fluids containing infection-causing bacteria.
- the invention also contemplates, in an alternative embodiment, molding the housing portion of such medical devices with an antimicrobial additive, although under some circumstances doing so may deleteriously effect the physical properties of the housing.
- an antimicrobial additive to be effective in killing infection-causing bacteria, it is necessary that the antimicrobial material be at least partially exposed on at least one surface of the medical device component which communicates with a fluid path in the device. It may be possible to promote migration of the antimicrobial additive to the surface of molded resin parts by utilizing lower injection pressures, lower injection speed and colder mold temperatures during the injection molding process.
- a plasma ablation treatment in which the medical device component is exposed to an oxygen- containing plasma, and preferably an oxygen/carbon tetrafluoride (0 2 /CF 4 ) plasma for approximately five minutes.
- the effect of such a plasma ablation treatment is represented in Figs. 6A and 6B, which show, respectively, an antimicrobial-containing resin component before and after the surface treatment. As shown in Fig. 6B, some of the resin material has been removed from surface 26 and thus a greater amount of the antimicrobial agent 24 is exposed at the new surface 26'.
- the fluid-contacting surface or surfaces of an access control member used in a medical device of the present invention may have a coating of elemental silver adhesively secured thereto by means of a standard, hot stamp transfer procedure.
- a silver-containing coating or film 62 is created by standard techniques, i.e., laying down a thin film of elemental silver on a polyester film, followed by an adhesive, and this film 62 is subsequently transferred to the surface 64 of the access control member to which it is adhesively secured.
- the surface 68 of a medical device component 66 which is to be in communication with a fluid path has a thin film 70 of an antimicrobial (e.g., elemental silver) deposited thereon by electron beam, DC or RF sputtering.
- an antimicrobial e.g., elemental silver
- ion beam implantation can be used following the thin film deposition to mix the deposited silver atoms into the surface.
- Ion beam enhanced deposition contemplates depositing the thin film of silver concurrent with ion beam bombardment. This approach optimizes adhesion of the silver to the surface.
- Thin film deposition, ion beam implantation, and ion beam enhanced deposition are all well known techniques for depositing and implanting thin metal films and ions onto exposed surfaces.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94912179A EP0691869A1 (en) | 1993-03-30 | 1994-03-03 | Medical devices having antimicrobial properties and methods of making and using |
JP6522068A JPH08508421A (en) | 1993-03-30 | 1994-03-03 | Antibacterial medical device and method of manufacturing and using the same |
AU64433/94A AU6443394A (en) | 1993-03-30 | 1994-03-03 | Medical devices having antimicrobial properties and methods of making and using |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3991693A | 1993-03-30 | 1993-03-30 | |
US08/039,916 | 1993-03-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1994022522A1 true WO1994022522A1 (en) | 1994-10-13 |
Family
ID=21908035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1994/002327 WO1994022522A1 (en) | 1993-03-30 | 1994-03-03 | Medical devices having antimicrobial properties and methods of making and using |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0691869A1 (en) |
JP (1) | JPH08508421A (en) |
AU (1) | AU6443394A (en) |
CA (1) | CA2158477A1 (en) |
WO (1) | WO1994022522A1 (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001007102A2 (en) * | 1999-07-27 | 2001-02-01 | Alaris Medical Systems, Inc. | Needleless medical connector with expandable valve mechanism |
US7160272B1 (en) | 2002-05-31 | 2007-01-09 | Elcam Plastic | Y-site medical valve |
US7771383B2 (en) | 2004-10-22 | 2010-08-10 | Medegen, Inc. | Fluid control device with valve and methods of use |
WO2011048204A3 (en) * | 2009-10-23 | 2011-06-23 | Hopf Hans-Juergen | Selector valve having antiseptically and/or antimicrobially acting surfaces |
US20150231309A1 (en) * | 2014-02-20 | 2015-08-20 | Becton, Dickinson And Company | Antimicrobial inserts for medical devices |
US20150231307A1 (en) * | 2014-02-20 | 2015-08-20 | Becton, Dickinson And Company | Antimicrobial inserts for medical devices |
WO2015179548A2 (en) | 2014-05-21 | 2015-11-26 | Attwill Medical Solutions Steriflow L.P. | Insert for catheter system |
WO2015164130A3 (en) * | 2014-04-23 | 2015-12-30 | Becton, Dickinson And Company | Antimicrobial stopcock medical connector |
US20160213911A1 (en) * | 2015-01-27 | 2016-07-28 | Becton, Dickinson And Company | Antimicrobial inserts for stopcock medical connectors |
US20160279327A1 (en) * | 2011-09-02 | 2016-09-29 | Carefusion 303, Inc. | Port-flushing control valve |
US9675793B2 (en) | 2014-04-23 | 2017-06-13 | Becton, Dickinson And Company | Catheter tubing with extraluminal antimicrobial coating |
US9695323B2 (en) | 2013-02-13 | 2017-07-04 | Becton, Dickinson And Company | UV curable solventless antimicrobial compositions |
US9750928B2 (en) | 2013-02-13 | 2017-09-05 | Becton, Dickinson And Company | Blood control IV catheter with stationary septum activator |
US9789279B2 (en) | 2014-04-23 | 2017-10-17 | Becton, Dickinson And Company | Antimicrobial obturator for use with vascular access devices |
US10232088B2 (en) | 2014-07-08 | 2019-03-19 | Becton, Dickinson And Company | Antimicrobial coating forming kink resistant feature on a vascular access device |
US10376686B2 (en) | 2014-04-23 | 2019-08-13 | Becton, Dickinson And Company | Antimicrobial caps for medical connectors |
US10426943B2 (en) | 2011-08-11 | 2019-10-01 | Attwill Medical Solutions Sterilflow L.P. | Insert for luer connection |
US10493244B2 (en) | 2015-10-28 | 2019-12-03 | Becton, Dickinson And Company | Extension tubing strain relief |
US11413376B2 (en) | 2015-03-30 | 2022-08-16 | C. R. Bard, Inc. | Application of antimicrobial agents to medical devices |
US11752242B2 (en) | 2015-06-11 | 2023-09-12 | Ath Therapeutics Inc. | Medical devices, systems, and methods utilizing antithrombin-heparin composition |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3342392B1 (en) * | 2012-02-02 | 2019-06-26 | Becton Dickinson Holdings Pte. Ltd. | Adaptor for coupling with a medical container |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4054139A (en) * | 1975-11-20 | 1977-10-18 | Crossley Kent B | Oligodynamic catheter |
EP0070087A1 (en) * | 1981-06-05 | 1983-01-19 | Baxter Travenol Laboratories, Inc. | Connector member adapted for ultraviolet antimicrobial irradiation |
US4483688A (en) * | 1980-09-22 | 1984-11-20 | Hiroshi Akiyama | Catheter |
WO1989001793A1 (en) * | 1987-08-29 | 1989-03-09 | Giltech Limited | Apparatus for antimicrobial use |
DE9100743U1 (en) * | 1991-01-23 | 1991-04-11 | Vygon Gmbh & Co Kg, 5100 Aachen, De | |
WO1991012838A1 (en) * | 1990-03-01 | 1991-09-05 | The Regents Of The University Of Michigan | Implantable infusion device |
-
1994
- 1994-03-03 WO PCT/US1994/002327 patent/WO1994022522A1/en not_active Application Discontinuation
- 1994-03-03 AU AU64433/94A patent/AU6443394A/en not_active Abandoned
- 1994-03-03 CA CA002158477A patent/CA2158477A1/en not_active Abandoned
- 1994-03-03 JP JP6522068A patent/JPH08508421A/en not_active Ceased
- 1994-03-03 EP EP94912179A patent/EP0691869A1/en not_active Withdrawn
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4054139A (en) * | 1975-11-20 | 1977-10-18 | Crossley Kent B | Oligodynamic catheter |
US4483688A (en) * | 1980-09-22 | 1984-11-20 | Hiroshi Akiyama | Catheter |
EP0070087A1 (en) * | 1981-06-05 | 1983-01-19 | Baxter Travenol Laboratories, Inc. | Connector member adapted for ultraviolet antimicrobial irradiation |
WO1989001793A1 (en) * | 1987-08-29 | 1989-03-09 | Giltech Limited | Apparatus for antimicrobial use |
WO1991012838A1 (en) * | 1990-03-01 | 1991-09-05 | The Regents Of The University Of Michigan | Implantable infusion device |
DE9100743U1 (en) * | 1991-01-23 | 1991-04-11 | Vygon Gmbh & Co Kg, 5100 Aachen, De |
Cited By (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001007102A3 (en) * | 1999-07-27 | 2002-01-17 | Alaris Medical Syst Inc | Needleless medical connector with expandable valve mechanism |
US6706022B1 (en) | 1999-07-27 | 2004-03-16 | Alaris Medical Systems, Inc. | Needleless medical connector with expandable valve mechanism |
EP1563867A2 (en) * | 1999-07-27 | 2005-08-17 | ALARIS Medical Systems, Inc. | Needleless medical connector with expandable valve mechanism |
EP1563867A3 (en) * | 1999-07-27 | 2005-10-12 | ALARIS Medical Systems, Inc. | Needleless medical connector with expandable valve mechanism |
US7184825B2 (en) | 1999-07-27 | 2007-02-27 | Cardinal Health 303, Inc. | Needless medical connector having antimicrobial agent |
WO2001007102A2 (en) * | 1999-07-27 | 2001-02-01 | Alaris Medical Systems, Inc. | Needleless medical connector with expandable valve mechanism |
US7160272B1 (en) | 2002-05-31 | 2007-01-09 | Elcam Plastic | Y-site medical valve |
US9782576B2 (en) | 2004-10-22 | 2017-10-10 | Carefusion 303, Inc. | Fluid control device with valve and methods of use |
US7771383B2 (en) | 2004-10-22 | 2010-08-10 | Medegen, Inc. | Fluid control device with valve and methods of use |
US8715222B2 (en) | 2004-10-22 | 2014-05-06 | Carefusion 303, Inc. | Fluid control device with valve and methods of use |
WO2011048204A3 (en) * | 2009-10-23 | 2011-06-23 | Hopf Hans-Juergen | Selector valve having antiseptically and/or antimicrobially acting surfaces |
US10426943B2 (en) | 2011-08-11 | 2019-10-01 | Attwill Medical Solutions Sterilflow L.P. | Insert for luer connection |
US10561786B2 (en) * | 2011-09-02 | 2020-02-18 | Carefusion 303, Inc. | Port-flushing control valve |
US11896802B2 (en) | 2011-09-02 | 2024-02-13 | Carefusion 303, Inc. | Port-flushing control valve |
US11426516B2 (en) | 2011-09-02 | 2022-08-30 | Carefusion 303, Inc. | Port-flushing control valve |
US20160279327A1 (en) * | 2011-09-02 | 2016-09-29 | Carefusion 303, Inc. | Port-flushing control valve |
US9695323B2 (en) | 2013-02-13 | 2017-07-04 | Becton, Dickinson And Company | UV curable solventless antimicrobial compositions |
US11357962B2 (en) | 2013-02-13 | 2022-06-14 | Becton, Dickinson And Company | Blood control IV catheter with stationary septum activator |
US9750928B2 (en) | 2013-02-13 | 2017-09-05 | Becton, Dickinson And Company | Blood control IV catheter with stationary septum activator |
US11931483B2 (en) | 2014-02-20 | 2024-03-19 | Becton, Dickinson And Company | Antimicrobial inserts for medical devices |
US20200390942A1 (en) * | 2014-02-20 | 2020-12-17 | Becton, Dickinson And Company | Antimicrobial inserts for medical devices |
US11291749B2 (en) | 2014-02-20 | 2022-04-05 | Becton, Dickinson And Company | Antimicrobial inserts for medical devices |
US20150231307A1 (en) * | 2014-02-20 | 2015-08-20 | Becton, Dickinson And Company | Antimicrobial inserts for medical devices |
US10792399B2 (en) | 2014-02-20 | 2020-10-06 | Becton, Dickinson And Company | Antimicrobial inserts for medical devices |
US10792398B2 (en) | 2014-02-20 | 2020-10-06 | Becton, Dickinson And Company | Antimicrobial inserts for medical devices |
US20150231309A1 (en) * | 2014-02-20 | 2015-08-20 | Becton, Dickinson And Company | Antimicrobial inserts for medical devices |
WO2015164130A3 (en) * | 2014-04-23 | 2015-12-30 | Becton, Dickinson And Company | Antimicrobial stopcock medical connector |
US9789279B2 (en) | 2014-04-23 | 2017-10-17 | Becton, Dickinson And Company | Antimicrobial obturator for use with vascular access devices |
US10376686B2 (en) | 2014-04-23 | 2019-08-13 | Becton, Dickinson And Company | Antimicrobial caps for medical connectors |
US10149971B2 (en) | 2014-04-23 | 2018-12-11 | Becton, Dickinson And Company | Antimicrobial stopcock medical connector |
AU2015250120B2 (en) * | 2014-04-23 | 2019-10-03 | Becton, Dickinson And Company | Antimicrobial stopcock medical connector |
CN106456963A (en) * | 2014-04-23 | 2017-02-22 | 贝克顿·迪金森公司 | Antimicrobial stopcock medical connector |
US10994118B2 (en) | 2014-04-23 | 2021-05-04 | Becton, Dickinson And Company | Antimicrobial stopcock medical connector |
US9675793B2 (en) | 2014-04-23 | 2017-06-13 | Becton, Dickinson And Company | Catheter tubing with extraluminal antimicrobial coating |
US10589063B2 (en) | 2014-04-23 | 2020-03-17 | Becton, Dickinson And Company | Antimicrobial obturator for use with vascular access devices |
US9956379B2 (en) | 2014-04-23 | 2018-05-01 | Becton, Dickinson And Company | Catheter tubing with extraluminal antimicrobial coating |
US11357965B2 (en) | 2014-04-23 | 2022-06-14 | Becton, Dickinson And Company | Antimicrobial caps for medical connectors |
WO2015179548A3 (en) * | 2014-05-21 | 2016-01-14 | Attwill Medical Solutions Steriflow L.P. | Insert for catheter system |
US10525192B2 (en) | 2014-05-21 | 2020-01-07 | Attwill Medical Solutions Steriflow L.P. | Insert for catheter system |
WO2015179548A2 (en) | 2014-05-21 | 2015-11-26 | Attwill Medical Solutions Steriflow L.P. | Insert for catheter system |
US10232088B2 (en) | 2014-07-08 | 2019-03-19 | Becton, Dickinson And Company | Antimicrobial coating forming kink resistant feature on a vascular access device |
US11077293B2 (en) | 2015-01-27 | 2021-08-03 | Becton, Dickinson And Company | Antimicrobial inserts for stopcock medical connectors |
WO2016122895A1 (en) * | 2015-01-27 | 2016-08-04 | Becton, Dickinson And Company | Antimicrobial inserts for stopcock medical connectors |
US20160213911A1 (en) * | 2015-01-27 | 2016-07-28 | Becton, Dickinson And Company | Antimicrobial inserts for stopcock medical connectors |
US11554259B2 (en) | 2015-01-27 | 2023-01-17 | Becton, Dickinson And Company | Antimicrobial inserts for stopcock medical connectors |
US10004890B2 (en) | 2015-01-27 | 2018-06-26 | Becton, Dickinson And Company | Antimicrobial inserts for stopcock medical connectors |
US11413376B2 (en) | 2015-03-30 | 2022-08-16 | C. R. Bard, Inc. | Application of antimicrobial agents to medical devices |
US11759551B2 (en) | 2015-03-30 | 2023-09-19 | C. R. Bard, Inc. | Application of antimicrobial agents to medical devices |
US11752242B2 (en) | 2015-06-11 | 2023-09-12 | Ath Therapeutics Inc. | Medical devices, systems, and methods utilizing antithrombin-heparin composition |
US11904114B2 (en) | 2015-10-28 | 2024-02-20 | Becton, Dickinson And Company | Extension tubing strain relief |
US10493244B2 (en) | 2015-10-28 | 2019-12-03 | Becton, Dickinson And Company | Extension tubing strain relief |
Also Published As
Publication number | Publication date |
---|---|
AU6443394A (en) | 1994-10-24 |
CA2158477A1 (en) | 1994-10-13 |
EP0691869A1 (en) | 1996-01-17 |
JPH08508421A (en) | 1996-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1994022522A1 (en) | Medical devices having antimicrobial properties and methods of making and using | |
US20220265986A1 (en) | Blood control iv catheter with stationary septum activator | |
CA2183164C (en) | Antibacterial medical tubing connector | |
US9770580B2 (en) | Blood control IV catheter with antimicrobial properties | |
EP2783708B1 (en) | Elastomeric septum having a polymeric coating | |
EP2272545B1 (en) | Antimicrobial medical devices and methods of preparation thereof | |
EP2047161B1 (en) | Vascular access device non-adhering membranes | |
US20190314602A1 (en) | Antimicrobial actuator for opening the side port of a ported catheter | |
CA2938600C (en) | Antimicrobial inserts for medical devices | |
WO2000033895A1 (en) | Preventing and removing biofilm from the surface of medical devices | |
US20120078203A1 (en) | Antimicrobial injection port barrier cover | |
JP2018510003A (en) | Application of antibacterial agents to medical devices | |
Bambauer et al. | Large bore catheters with surface treatments versus untreated catheters for vascular access in hemodialysis | |
Bambauer et al. | Long‐term catheters for apheresis and dialysis with surface treatment with infection resistance and low thrombogenicity | |
Bambauer et al. | Large bore catheters with surface treatments versus untreated catheters for blood access | |
Jansen | New concepts in the prevention of polymer-associated foreign body infections | |
Bambauer et al. | Scanning electron microscopic investigation of catheters for blood access |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB HU JP KP KR KZ LK LU LV MG MN MW NL NO NZ PL PT RO RU SD SE SI SK UA UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2158477 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1994912179 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1994912179 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1994912179 Country of ref document: EP |